Stock Events

Stock Events

Search...

Conduit Pharmaceuticals

$0.25

4

+$0+1.24% Friday 20:00

Statistics

Day High

0.25

Day Low

0.23

52W High

7.83

52W Low

0.21

Volume

1,305,322

Avg. Volume

8,561,407

Mkt Cap

18.09M

P/E Ratio

0

Dividend Yield

-

Dividend

-

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CDT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Pfizer is a major player in the pharmaceutical industry, directly competing in several therapeutic areas that Conduit Pharmaceuticals targets.

Merck operates globally in various pharmaceutical sectors, including those where Conduit Pharmaceuticals has significant investments.

Johnson & Johnson

Johnson & Johnson offers a wide range of pharmaceutical products that compete across multiple segments with Conduit Pharmaceuticals.

AbbVie competes in the biopharmaceutical field, particularly in areas like immunology and oncology, overlapping with Conduit's interests.

Amgen focuses on biotechnological medicines, including treatments in areas where Conduit Pharmaceuticals is actively researching.

Bristol-Myers Squibb

Bristol-Myers Squibb has a strong portfolio in areas like cancer and cardiovascular diseases, directly competing with Conduit's product lines.

Gilead Sciences

Gilead Sciences specializes in antiviral drugs and other areas that are key focus points for Conduit Pharmaceuticals.

Novartis is a global healthcare company that produces drugs in direct competition with several of Conduit Pharmaceuticals' products.

Sanofi operates globally, offering drugs that compete in the same categories as Conduit Pharmaceuticals.

Eli Lilly and Company is involved in pharmaceutical development in areas like diabetes and cancer, competing with Conduit Pharmaceuticals.

About

Conduit Pharmaceuticals Inc. operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. It's pipeline includes AZD1656 for the treatment of hashimoto's thyroiditis, renal transplant, uveitis, and preterm labor; and AZD5904 for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.

Show more...

CEO

Employees

7

Country

US

ISIN

US20678X1063

WKN

000A3EUWC

Listings